Butterfly Network, Inc. (BFLY) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Butterfly Network, Inc. is a digital health company developing portable, semiconductor-based ultrasound technology. The company operates as a single reportable segment, selling hardware (probes, chips) and software/services (SaaS, support) to healthcare systems and providers globally.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenue | $21.2 million | $17.7 million |
| Gross Profit | $13.4 million | $10.3 million |
| Gross Margin | 63.0% | 58.2% |
| Net Loss | $(14.0) million | $(21.8) million |
| Net Loss Per Share (Basic/Diluted) | $(0.06) | $(0.10) |
| Cash and Cash Equivalents | $155.2 million | $112.7 million (Q1 2024) |
| Operating Cash Flow | $(11.7) million | $(20.7) million |
| Debt | No floating rate debt; lease obligations of $27.1M total | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 20.2% year-over-year. Product revenue grew 25.4% driven by higher US sales volume, the higher selling price of the iQ3 probe, and semiconductor chip sales to a partner. Software and services revenue grew 10.9%.
- Margin Expansion: Gross margin improved to 63.0% from 58.2%, aided by a decrease in capitalized software amortization and lower payroll/cloud costs.
- Expense Management: Operating expenses decreased slightly to $31.8 million (from $32.9 million). R&D expenses dropped 7.4% due to personnel reductions from a 2024 transformation initiative. "Other" expenses (litigation/legal) fell 48.1%.
- Liquidity Event: On January 31, 2025, the company completed a public offering of 27.6 million shares, raising $81.1 million in net proceeds. This significantly bolstered cash reserves.
- Units Fulfilled: Increased by 10.9% compared to Q1 2024.
Outlook, Risks, and Commentary
- Liquidity Position: Management expects existing cash and operating cash flows to fund operations for at least the next 12 months. Annual cash requirements have been reduced to less than $50 million.
- Revenue Mix: The software and services mix decreased to 33.3% (from 36.1%) due to faster hardware growth, though the company expects a long-term shift toward software as device adoption increases.
- Legal Contingencies: The company is defending against a putative class action lawsuit (Rose v. Butterfly Network) and two stockholder derivative actions. Management cannot estimate potential losses but intends to vigorously defend these matters.
- Risk Factors: Key risks include the ability to attract/retain customers, regulatory authorization for products, competition from larger firms, and potential impacts of tariffs or economic downturns.
Investor Verification Checklist
- Verify the sustainability of the 25.4% product revenue growth, specifically the contribution from the one-time semiconductor chip sale to a partner.
- Monitor the trajectory of the software/services revenue mix, which declined in Q1 despite long-term strategic goals.
- Review the status of ongoing litigation (Rose and derivative suits) for any updates on settlement potential or legal costs.
- Assess the burn rate relative to the new $155.2 million cash balance to confirm the "12-month runway" assertion.
- Track the impact of the business transformation initiative on future R&D capabilities and product development timelines.